Medical abortion

From Wikipedia, the free encyclopedia

(Redirected from Chemical abortion)
Jump to: navigation, search
Methods of abortion
Part of the abortion series
Surgical
Medical

A medical abortion is a type of non-surgical abortion in which a drug is used to induce the abortion.

Contents

  • A follow-up appointment to make sure the abortion was complete. Manual vacuum aspiration may be performed in the event of incomplete abortion.

Each medical abortion drug has a unique mechanism of action.

  • Mifepristone binds to the progesterone receptor to block progesterone. Progesterone is necessary for pregnancy maintenance. Mifepristone also softens and dilates the cervix, and causes decidual necrosis (which leads to placental detachment). In addition, it increases prostaglandin release from the uterine lining, increases uterine contractions, and enhances uterine sensitivity to prostaglandin.
  • Methotrexate blocks an enzyme necessary for DNA synthesis, thus inhibiting the growth of rapidly dividing placental trophoblastic cells.

Both mifespristone and methotrexate are followed up with a prostaglandin drug in medically approved medical abortion regimens--misoprostol or gemeprost.

  • Misoprostol works by softening and dilating the cervix, and binding to myometrial cells to cause strong uterine contractions. Contractions cause expulsion of the embryo.

Misoprostol has been used alone for abortion since the 1970s. Alone, it has a higher rate of incomplete abortion than when combined with mifepristone or methotrexate. There have been reports of infections, such as toxic shock syndrome, following medical abortions, but the risk of such infection is relatively rare.

In the US, medical abortion is available at women’s health care centers, private clinics, and Planned Parenthood . The price ranges from about $350 to $575, depending on which medical tests are required.

In Canada, availability is much the same, however in some provinces the procedure is fully covered by the provincial health care plan. Prices in areas where abortion is not covered by provincial health care usually range from $250 to $400.

Mifepristone was first licensed in France in 1988. It is now approved in 29 countries, including Austria, Belgium, China, Denmark, Finland, Great Britain, Israel, Norway, Russia, South Africa, Sweden, and Taiwan. In 1993 President Clinton signed an executive order to encourage testing, licensing, and manufacturing of mifepristone in the United States. In 2000 the US Food and Drug Administration (FDA) approved the use of mifepristone for medical abortion in the United States.

It is currently possible to get mifepristone (the most common drug used in combination with a synthetic prostaglandin for medical abortion) in 60 clinics/centers in the United States.

Clinical trials of RU486 are currently being done in Canada in the cities of Edmonton, Winnipeg, Ottawa, Toronto, Montreal, Halifax and St. John's Newfoundland. The drug cannot be imported for personal use. However, medical abortions using Methotrexate and Misoprostol are available in Canada.


  • Trussell J, Ellertson C (Sep 1999). "Estimating the efficacy of medical abortion.". Contraception 60 (3): 119-35. PMID 10640155. 
  • Cabezas E (Dec 1998). "Medical versus surgical abortion.". Int J Gynaecol Obstet 63 Suppl 1: S141-6. PMID 10075224. 
  • Women on Web Online medical abortion service - for women in countries where access to safe abortion is restricted


Advanced Search
Included Web Search Engines


Safe Search

close

Top Matching Results

Occasionally Search.com will highlight specialized results that are based on the context of your query. Examples of specialized results include specific links to news, images, or video.

Top Matching Results may highlight information from other Search.com pages, content from the CNET Network of sites, or third party content. The listings are based purely on relevance. Search.com does not receive payment for listings in this section but our partners that provide this data may get paid for listing these products.

Sponsored Links

This section contains paid listings which have been purchased by companies that want to have their sites appear for specific search terms and related content. These listings are administered, sorted and maintained by a third party and are not endorsed by Search.com.

Search Results

Search.com sends your search query to several search engines at one time and integrates the results into one list which has been sorted by relevance using Search.com's proprietary algorithm. You can customize the list of search engines included in your metasearch from the preferences.

The search engines that are used in your metasearch may allow companies to pay to have their Web sites included within the results. To view the Paid Inclusion policy for a specific search engine, please visit their Web site. Search.com does not accept payment or share revenue with any search engine partner for listings in this section.